National Cancer Institute (NIH)
Featured Topics in Government Research Laboratories: Swiss Federal Institute of Technology | Fermi National Accelerator Laboratory (DOE) | Stanford Linear Accelerator Center (DOE) | National Cancer Institute (NIH) | Industrial Technology Research Institute | all topics
Filter by: News | Articles | New to Market | Tools & Technology | Videos | Podcasts | Journal Articles | White Papers
6/28/2011 | News
In
2008, Stanford researchers demonstrated the use of nanoparticle-aided
Raman spectroscopy to look at microscopic structures, including nascent
tumors, deep inside the body. That team has now conducted extensive
preclinical tests and shown that the gold nanoparticles can be safely
administered into the colon and used with a Raman endoscope to image the
inside of the large intestines.
3/3/2011 | News
In an effort to identify cancer earlier on, researchers at NIST and the National Cancer Institute have developed a technique that slices off the top of a cell and makes the structures accessible to spectroscopic examination of their chemical "signature."
11/19/2010 | News
A new form of x-ray microscopy pioneered by researchers
at the National Cancer Institute and the Helmholtz Association in
Germany can take images of small cellular components in their natural
environment, all while the cell remains completely intact. There is no
need to chemically fix, stain, or cut the cells.
9/13/2010 | News
Reflecting
the fortunes of a struggling economy, government R&D funding for
2011 is expected to slip about three-tenths of one percent from 2010
levels. The big news from the proposed package, however, is a marked
fall in defense R&D: 6.6%. As a result, non-defense R&D could rise by several percentage points.
9/24/2009 | News
Lab-on-a-chip technology is nothing new, but performing 1,000 chemical reactions at once on a single chip the size of a fingernail is an accomplishment that just put microfluidics near the top of the toolkits for drug discovery efforts, as well as other chemical reaction evaluations. The reaction method is in situ click chemistry, in which potential drug molecules bind to protein enzymes that are then analyzed with mass spectrometry.
